Accessibility settings

Published on in Vol 6, No 4 (2018): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9115, first published .
Man's hands using a smartphone with glowing screen

Mobile App Usage Patterns of Patients Prescribed a Smoking Cessation Medicine: Prospective Observational Study

Mobile App Usage Patterns of Patients Prescribed a Smoking Cessation Medicine: Prospective Observational Study

Journals

  1. De Bruijn G, Dallinga J, Deutekom M. Predictors of Walking App Users With Comparison of Current Users, Previous Users, and Informed Nonusers in a Sample of Dutch Adults: Questionnaire Study. JMIR mHealth and uHealth 2021;9(5):e13391 View
  2. Vilardaga R, Casellas-Pujol E, McClernon J, Garrison K. Mobile Applications for the Treatment of Tobacco Use and Dependence. Current Addiction Reports 2019;6(2):86 View
  3. Kruse G, Park E, Shahid N, Abroms L, Haberer J, Rigotti N. Combining Real-Time Ratings With Qualitative Interviews to Develop a Smoking Cessation Text Messaging Program for Primary Care Patients. JMIR mHealth and uHealth 2019;7(3):e11498 View
  4. Nghiem N, Leung W, Cleghorn C, Blakely T, Wilson N. Mass media promotion of a smartphone smoking cessation app: modelled health and cost-saving impacts. BMC Public Health 2019;19(1) View
  5. Amagai S, Pila S, Kaat A, Nowinski C, Gershon R. Challenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review. Journal of Medical Internet Research 2022;24(4):e35120 View
  6. Coindard G, Acquadro M, Chaumont R, Arnould B, Boisnault P, Collignon-Portes R, Duhot D, Raineri F, Tugaut B, Aubin H. Attitudes & behaviors toward the management of tobacco smoking patients: qualitative study with French primary care physicians. BMC Primary Care 2022;23(1) View
  7. Izuo N, Miyanishi H, Nishizawa D, Fujii T, Hasegawa J, Sato N, Tanioka F, Sugimura H, Ikeda K, Nitta A. DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers. Neuropsychopharmacology Reports 2023;43(4):570 View
  8. Sifat M, Hébert E, Ahluwalia J, Businelle M, Waring J, Frank-Pearce S, Bryer C, Benson L, Madison S, Planas L, Baranskaya I, Kendzor D. Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial. JMIR Formative Research 2023;7:e48857 View
  9. Mansour M, Busschers W, Crone M, van Asselt K, van Weert H, Chavannes N, Meijer E. Use of the Smoking Cessation App Ex-Smokers iCoach and Associations With Smoking-Related Outcomes Over Time in a Large Sample of European Smokers: Retrospective Observational Study. Journal of Medical Internet Research 2023;25:e45223 View
  10. Minian N, Mehra K, Rose J, Veldhuizen S, Zawertailo L, Ratto M, Lecce J, Selby P. Cocreation of a conversational agent to help patients adhere to their varenicline treatment: A study protocol. DIGITAL HEALTH 2023;9 View
  11. Hewage S, Kularatna S, Parsonage W, Walters T, McPhail S, Brain D, Allen M. Integrating a Mobile App to Enhance Atrial Fibrillation Care: Key Insights From an Implementation Study Guided by the Consolidated Framework for Implementation Research. Journal of Medical Internet Research 2025;27:e66815 View
  12. Kamaludin I, Yee A, Sin How L, Danaee M, Amer Nordin A, Wei Yeong K, Yusoff Z, Yiik Sang W, Hairi F. “Getting every smoker to participate and quit - GEMPAQ V2.0”, a personalised smoking cessation smartphone app in Malaysia: A pilot randomised controlled trial. DIGITAL HEALTH 2026;12 View